Metraipolis › archive › dc_cd0805151a8f

Gamma-glutamyl metformin inhibits renal cell carcinoma progression by activating AMPK signaling pathway — Europe PMC PMID:42181886

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42181886
DOI
10.3389/fphar.2026.1807987
License (as archived)
solo-consultazione
Archived
2026-11-02T16:34:53.870Z
SHA-256 of the archived text
96c34269e205b841347b67f322ab31c180512e0226126a15d39daaccf3f07cbd
Stable URL of this page
https://metraipolis.com/documento/dc_cd0805151a8f

How to cite

Gamma-glutamyl metformin inhibits renal cell carcinoma progression by activating AMPK signaling pathway — Europe PMC PMID:42181886 — Europe PMC (en), https://europepmc.org/article/MED/42181886 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd0805151a8f (Metraipolis archive dc_cd0805151a8f, sha256 96c34269e205b841347b67f322ab31c180512e0226126a15d39daaccf3f07cbd)
BibTeX
@misc{dccd0805151a8f,
  title = {Gamma-glutamyl metformin inhibits renal cell carcinoma progression by activating AMPK signaling pathway — Europe PMC PMID:42181886},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42181886},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd0805151a8f; sha256 96c34269e205b841347b67f322ab31c180512e0226126a15d39daaccf3f07cbd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42181886. Agents can read the archived copy with the MCP tool read_document.